TY  - JOUR
AU  - Marín-Pozo, Juan F
AU  - Duarte-Pérez, Juan M
AU  - Sánchez-Rovira, Pedro
PY  - 2016
DO  - 10.1097/MD.0000000000003623
UR  - http://hdl.handle.net/10668/10077
T2  - Medicine
AB  - To evaluate the safety and efficacy of bevacizumab in a broader patient population with solid tumors in the context of general clinical practice. Moreover, we quantified the economic impact and characterized the off-label use (OLU) of this agent in...
LA  - en
KW  - Aged
KW  - Angiogenesis Inhibitors
KW  - Bevacizumab
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - Off-Label Use
KW  - Retrospective Studies
KW  - Spain
KW  - Time Factors
TI  - Safety, Effectiveness, and Costs of Bevacizumab-Based Therapy in Southern Spain: A Real World Experience.
TY  - research article
VL  - 95
ER  -